Insider Trading March 5, 2026

Slide Insurance Director Sells $193,300 in Shares After Exercising Options

Stephen L. Rohde disposed of 10,000 shares in two tranches and exercised options for 10,000 shares as Slide Insurance reports strong fourth-quarter results

By Avery Klein SLDE
Slide Insurance Director Sells $193,300 in Shares After Exercising Options
SLDE

Stephen L. Rohde, a director at Slide Insurance Holdings, Inc. (NYSE: SLDE), sold 10,000 shares across March 3 and March 4, 2026, for about $193,300 and simultaneously exercised options to buy 10,000 shares for $0.0018 each. The transactions occurred as SLDE stock has risen 42% over six months and after the company reported a sizable fourth-quarter 2025 earnings beat and strong revenue growth.

Key Points

  • Stephen L. Rohde sold 10,000 shares in two tranches on March 3 and March 4, 2026, totaling roughly $193,300.
  • Rohde exercised options to acquire 10,000 shares at $0.0018 per share on the same days, for a total exercise cost of $18.
  • Slide Insurance reported Q4 2025 EPS of $1.23 versus an expected $0.71 and revenue of $347 million, while the stock has risen 42% over the past six months.

Stephen L. Rohde, a member of the board of Slide Insurance Holdings, Inc. (NYSE: SLDE), completed the sale of 10,000 shares of the company’s common stock in two separate transactions on March 3 and March 4, 2026, realizing roughly $193,300 in proceeds.

Details disclosed in a Form 4 filing with the Securities and Exchange Commission show the trades were executed in equal tranches. On March 3, Mr. Rohde sold 5,000 shares at $19.16 per share. The following day he sold another 5,000 shares at $19.50 per share.

On the same dates as the sales, Mr. Rohde exercised stock options that allowed him to acquire 10,000 shares of Slide Insurance common stock at an exercise price of $0.0018 per share. The total cash required to exercise those options amounted to $18.

The insider activity comes amid a period of notable share-price appreciation for Slide Insurance. Over the past six months the stock has climbed 42%, and at the time of reporting shares were trading at $19.47. The company’s price-to-earnings ratio stands at 5.71.

Separately, analysis from InvestingPro cited in the filing indicates the stock appears undervalued at current levels and assigns the company an "EXCELLENT" financial health score of 3.98 out of 5.

Slide Insurance published fourth-quarter 2025 results that exceeded analysts’ expectations. The company reported earnings per share of $1.23, versus the $0.71 consensus estimate, a surprise of 73.24%. Revenue for the quarter came in at $347 million, up from $238.5 million in the same period a year earlier.

Analysts had projected lower figures for the quarter. The company’s stronger-than-expected earnings and revenue performance, combined with the recent stock appreciation, has been highlighted in public disclosures as likely to draw increased attention from investors and analysts. The filings note that these results could affect future analyst assessments and investor interest.


Context and takeaways

  • Director Stephen L. Rohde sold a total of 10,000 shares on March 3 and March 4, 2026, in two equal tranches at $19.16 and $19.50 per share.
  • On the same days, he exercised options to acquire 10,000 shares at $0.0018 per share, requiring $18 in total.
  • Slide Insurance’s Q4 2025 results beat expectations with EPS of $1.23 and revenue of $347 million, and the stock has risen 42% over the past six months.

The information above is drawn from the company’s Form 4 filing and the company’s reported quarterly results.

Risks

  • Market and investor reaction to the insider transactions and the company’s recent earnings beat may be uncertain and could influence future analyst assessments and investor interest.
  • Valuation metrics cited, including InvestingPro’s assessment that the stock appears undervalued, are analytic conclusions and may not eliminate the potential for future volatility in the insurance and equities markets.

More from Insider Trading

GigaCloud CEO and Affiliated Entities Dispose of $5.4M in Shares Under 10b5-1 Plan Mar 5, 2026 PAR Technology CLO Executes $134,562 in Mandatory Sell-to-Cover Transactions Mar 5, 2026 CoreWeave CFO Executes $286,935 Sale Under 10b5-1 Plan; Shares, Analyst Views Highlight Divergent Market Signals Mar 5, 2026 NextNav CEO Sells $1.18M in Stock as Company Advances Board and Japan 5G Deployment Mar 5, 2026 ITT CEO Savi Luca Sells $12 Million in Stock as Company Executes Major Acquisition and Posts Strong Q4 Mar 5, 2026